Type‑based segmentation of the Veterinary Splints market isolates five distinct product families that together shape the market’s revenue profile. External fixation splints, typically constructed from stainless‑steel or carbon‑fiber frames, dominate with an estimated 38 % share, driven by their superior load‑bearing capacity for large‑animal fractures. Bandage splints, employing elastic or semi‑rigid wraps, represent roughly 25 % of sales, favored in small‑animal clinics for ease of application and low material cost. Cast splints—often plaster or fiberglass composites—account for about 20 % of the market, reflecting their long‑standing clinical acceptance despite longer setting times. Modular polymer splints, featuring interchangeable components made from medical‑grade thermoplastics, contribute near 12 % as veterinarians seek customizable solutions for complex orthopedic cases. Finally, biodegradable splints hold a modest 5 % share, emerging from sustainability pressures and the need for implants that resorb without removal. Collectively, these product categories define the market taxonomy, with each type’s engineering attributes and cost structure influencing its proportional impact on total market size.